Lb Pharmaceuticals (LBRX) Tax Rate (2024 - 2025)
Lb Pharmaceuticals (LBRX) posted quarterly Tax Rate of 0.01% for Q4 2025, up 1.0% year-over-year from 0.01% in Q4 2024, and up 55.8% quarter-over-quarter from 0.02% in Q4 2024.
Powered by 
Analysis
Lb Pharmaceuticals (LBRX) Tax Rate (2024 - 2025) Analysis & Trends
Lb Pharmaceuticals' Tax Rate history runs 2 years deep, the most recent figure standing at 0.01% for Q4 2025.
- In Q4 2025, Tax Rate rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Tax Rate for Q4 2025 stood at 0.01%, up from 0.02% in the prior quarter.
- The five-year high for Tax Rate was 0.01% in Q4 2025, with the low at 0.02% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -16.71% |
| 10 | Lb Pharmaceuticals | 1.49 Bn | 1.49 Bn | - | - |